Weight Loss Brings Americans Big Health Care Savings
THURSDAY, Dec. 5, 2024 (HealthDay News) — The advent of GLP-1 weight-loss medications such as Wegovy and Zepbound has spurred debate as to whether the drugs’ cost should be covered by Medicare, Medicaid and private insurers. Late last month, the Biden administration proposed that the drugs be covered by MedicareContinue Reading